Coronary Artery Disease (CAD) is a world epidemic affecting over 110 million people and resulting in over 8.9 million deaths. It makes up 15.9% of all death making it the most common cause of death in the world. In the United States 20% of those over 65 have CAD. Likewise, Peripheral Arterial Disease (PAD) affects 155 million people worldwide. In 2015 it was responsible for over 52,500 deaths up from 16,000 deaths
in 1990. It carries a greater than 20% risk of a coronary event in 10 years and a 5-year mortality rate of 30%. The New York Coronary and Vascular Summit is organized in conjunction with Albert Einstein College of Medicine/Montefiore Medical Center faculty from the section of Cardiology. Guest faculty includes national and international though leaders in the field of Interventional Cardiology, Vascular Surgery and Interventional Radiology.
Conference Goals and Overview
The primary focus of this course is to present a multidisciplinary approach to revascularization of patients with complex coronary, and peripheral vascular disease. The critical role of percutaneous left ventricular support (Impella, Impella CP, Pecutaneous Heart Pump, R-Pella, ECMO), in supporting complex interventions will be discussed and emphasized on the case by case basis. Various interventional devices and techniques such as orbital atherectomy (OA), rotational atherectomy, laser atherectomy, and complex peripheral vascular intervention will be emphasized. Technical issues regarding retrograde CTO techniques both in coronary & peripheral cases, unprotected left main disease, heavily calcified lesions, bifurcation lesions,
total occlusions, thrombotic lesions, recurrent in-stent restenosis, carotid stenting, and pedal access for complex critical limb ischemia interventions will be discussed by the faculty using live case presentations as platforms using the live case format. Treatment of emerging problems, appropriateness of revascularization and evidence-based practice guidelines will be discussed while live cases are performed. Within the live case format, current topics will be presented to provide interventional cardiologists and vascular interventionalists with state-of-the-art information for managing patients as the dynamic field of interventional cardiology and endovascular intervention continues to evolve.
After attending this activity, participants will be able to:
Select the appropriate revascularization strategy in the treatment of unprotected left main disease.
Plan for the best interventional strategy with increasing wire escalations for revascularization of chronic total occlusion.
Apply case selection and choose the appropriate interventional devises for PAD treatment.
Choose the appropriate mechanical support devise in high risk coronary interventions in the setting of severe left ventricular dysfunction.
Understand the new technology, devises and approaches in the carotid stenting.
Discuss novel imaging approaches in CAD, Structural Heart Disease and PAD.
This activity is specifically designed for:
Interventional cardiologists who manage patients with complex coronary and vascular lesions for revascularization
Heart failure interventionist
Interventional radiologists and vascular surgeons
Cardiology fellows with an interest in Interventional Radiology and Endovascular Interventions
Nurses, technicians, and other allied health care professionals who work in Cardiac Catheterization and Vascular Laboratories
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this live activity for a maximum of 7.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Verification of Attendance
Verification of attendance will be provided to all professionals.
Should this activity receive support in part by educational grants or in-kind materials, in accordance with ACCME Standards appropriate acknowledgement will be given at the time of the activity. At the time of this printing, list of commercial supporters (financial or in-kind) was incomplete and not available.
Special Needs (ADA)
Albert Einstein College of Medicine Montefiore Medical Center fully complies with the legal requirements of the Americans with Disabilities Act. If any participant is in need of special accommodations, please submit a written request at least two weeks prior to the activity to Center for Continuing Medical Education, 3301 Bainbridge Avenue, Bronx, NY 10467.
Request for refunds MUST be received in writing by September 25, 2017 and will be subject to an administration fee of $35.00. NO REFUNDS WILL BE MADE AFTER THIS DATE.
Conflict of Interest
The “Conflict of Interest Disclosure Policy” of the Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a commercial interest; pharmaceutical or equipment company*. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device, not yet approved in the United States.
The staff of CCME of Albert Einstein College of Medicine have no conflicts of interest with commercial interests related directly or indirectly to this educational activity.
* The ACCME defines Commercial Interest as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interest.
Montefiore, Moses Campus
Tishman Learning Center
111 E. 210th Street
Bronx, NY 10467
P: (123) 456-7890
TAVR 2018 – Are We Ready for Prime Time in the Low Risk Patient?
Michael Mack, MD
Percutaneous Treatment for Mitral and Tricuspid Valves – What is State of the Art?
Post TAVR Rx of CAD
George Dangas, MD, PhD
Closing Remarks and Plans for Next Year’s Symposium
George Dangas, MD, PhD
As the academic medical center and University Hospital for Albert Einstein College of Medicine, Montefiore Medical Center is nationally recognized for clinical excellence—breaking new ground in research, training the next generation of healthcare leaders, and delivering science-driven, patient-centered care.
Montefiore is ranked among the top hospitals nationally and regionally by U.S. News & World Report. For more than 100 years we have been innovating new treatments, new procedures and new approaches to patient care, producing stellar outcomes and raising the bar for medical centers in the region and around the world. As we build on this momentum, we continue to advance the practice of medicine and set the standard for excellence.